Announcements
Milford Molecular Diagnostics Laboratory becomes the only laboratory to be certified according to the Clinical Laboratory Improvement Amendments (CLIA) requirements to perform the BRCA1 and BRCA2 Ashkenazi Jewish founder gene mutations screen on liquid-based cytology sample (SurePath or ThinPrep) on August 17, 2017.
Dr. Sin Hang Lee stated at a Massachusetts General Hospital roundtable discussion on November 8, 2014 that "Lyme disease, like Ebola, should be diagnosed by DNA sequencing." For more information, see the following attachment.
Dr. Sin Hang Lee was an invited speaker on DNA Sequencing Diagnosis of Spirochetemia in Lyme and Related Borrelioses at the ILADS Washington DC meeting on October 11, 2014.
Dr. Sin Hang Lee spoke at a scientific symposium on laboratory testing for spirochetemia in Borrelia burgdorferi and Borrelia miyamotoi infections sponsored by The Coalition Against Lyme and Related Borrelioses (CALRB) on September 16, 2014.
|
